Zurich Cantonal Bank’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,407
| Closed | -$86K | – | 2583 |
|
|
2018
Q1 | $86K | Hold |
4,407
| – | – | ﹤0.01% | 1689 |
|
|
2017
Q4 | $73K | Buy |
4,407
+1,232
| +39% | +$22.6K | ﹤0.01% | 1784 |
|
|
2017
Q3 | $64K | Hold |
3,175
| – | – | ﹤0.01% | 1658 |
|
|
2017
Q2 | $51K | Buy |
3,175
+815
| +35% | +$12K | ﹤0.01% | 1753 |
|
|
2017
Q1 | $30K | Hold |
2,360
| – | – | ﹤0.01% | 2126 |
|
|
2016
Q4 | $31K | Hold |
2,360
| – | – | ﹤0.01% | 2074 |
|
|
2016
Q3 | $56K | Buy |
2,360
+241
| +11% | +$6.48K | ﹤0.01% | 1572 |
|
|
2016
Q2 | $61K | Hold |
2,119
| – | – | ﹤0.01% | 1417 |
|
|
2016
Q1 | $68K | Hold |
2,119
| – | – | ﹤0.01% | 1313 |
|
|
2015
Q4 | $91K | Buy |
2,119
+1,168
| +123% | +$46.7K | ﹤0.01% | 1182 |
|
|
2015
Q3 | $33K | Buy |
951
+706
| +288% | +$31.8K | ﹤0.01% | 1331 |
|
|
2015
Q2 | $11K | Hold |
245
| – | – | ﹤0.01% | 1352 |
|
|
2015
Q1 | $11K | Buy |
+245
| New | +$9.75K | ﹤0.01% | 1338 |
|
|
2014
Q3 | – | Sell |
-100,000
| Closed | -$3M | – | 1006 |
|
|
2014
Q2 | $3M | Buy |
100,000
+20,000
| +25% | +$540K | 0.09% | 288 |
|
|
2014
Q1 | $2.11M | Sell |
80,000
-100,000
| -56% | -$2.5M | 0.07% | 351 |
|
|
2013
Q4 | $4.53M | Buy |
+180,000
| New | +$4.02M | 0.15% | 147 |
|
Zurich Cantonal Bank's IPXL Position: Q2 2018 in Review
Zurich Cantonal Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 4,407 shares — an estimated $86K sold.
Zurich Cantonal Bank first reported a position in IPXL in Q4 2013 and held it in 16 quarters. The position peaked at $4.53M in Q4 2013. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Zurich Cantonal Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Zurich Cantonal Bank sold 4,407 Impax Laboratories, Inc. shares in Q2 2018, an estimated $86K.
- Zurich Cantonal Bank first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 16 quarters.
- Zurich Cantonal Bank's Impax Laboratories, Inc. position peaked at $4.53M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Zurich Cantonal Bank's 13F filing for Q2 2018, filed 6 Aug 2018.